Herpes zoster infection, vaccination and immunocompromised rheumatology patients.

Hdl Handle:
http://hdl.handle.net/10147/296779
Title:
Herpes zoster infection, vaccination and immunocompromised rheumatology patients.
Authors:
O'Connor, Mortimer B; Phelan, Mark J
Affiliation:
Department of Rheumatology, South Infirmary Victoria University Hospital, Cork, Ireland. mortimeroconnor@gmail.com
Citation:
Herpes zoster infection, vaccination and immunocompromised rheumatology patients. 2013, 33 (1):239-40 Rheumatol. Int.
Journal:
Rheumatology international
Issue Date:
Jan-2013
URI:
http://hdl.handle.net/10147/296779
DOI:
10.1007/s00296-011-2155-9
PubMed ID:
21947348
Abstract:
Varicella is a self-limiting and relatively mild disease of childhood, although it is frequently more severe and complicated among the immunocompromised rheumatology patients on immunomodulator therapies. In addition, future reactivation of the dormant virus in dorsal root ganglia may cause herpes zoster infection, which can be very debilitating. In this manuscript, we discuss the nature of this infection along with its potential vaccine especially among rheumatology patients.
Item Type:
Article
Language:
en
MeSH:
Antirheumatic Agents; Chickenpox; Chickenpox Vaccine; Humans; Immunocompromised Host; Immunosuppressive Agents; Rheumatic Diseases; Virus Activation
ISSN:
1437-160X

Full metadata record

DC FieldValue Language
dc.contributor.authorO'Connor, Mortimer Ben_GB
dc.contributor.authorPhelan, Mark Jen_GB
dc.date.accessioned2013-07-22T11:32:25Z-
dc.date.available2013-07-22T11:32:25Z-
dc.date.issued2013-01-
dc.identifier.citationHerpes zoster infection, vaccination and immunocompromised rheumatology patients. 2013, 33 (1):239-40 Rheumatol. Int.en_GB
dc.identifier.issn1437-160X-
dc.identifier.pmid21947348-
dc.identifier.doi10.1007/s00296-011-2155-9-
dc.identifier.urihttp://hdl.handle.net/10147/296779-
dc.description.abstractVaricella is a self-limiting and relatively mild disease of childhood, although it is frequently more severe and complicated among the immunocompromised rheumatology patients on immunomodulator therapies. In addition, future reactivation of the dormant virus in dorsal root ganglia may cause herpes zoster infection, which can be very debilitating. In this manuscript, we discuss the nature of this infection along with its potential vaccine especially among rheumatology patients.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to Rheumatology internationalen_GB
dc.subject.meshAntirheumatic Agents-
dc.subject.meshChickenpox-
dc.subject.meshChickenpox Vaccine-
dc.subject.meshHumans-
dc.subject.meshImmunocompromised Host-
dc.subject.meshImmunosuppressive Agents-
dc.subject.meshRheumatic Diseases-
dc.subject.meshVirus Activation-
dc.titleHerpes zoster infection, vaccination and immunocompromised rheumatology patients.en_GB
dc.typeArticleen
dc.contributor.departmentDepartment of Rheumatology, South Infirmary Victoria University Hospital, Cork, Ireland. mortimeroconnor@gmail.comen_GB
dc.identifier.journalRheumatology internationalen_GB
dc.description.fundingNo fundingen
dc.description.provinceMunsteren
dc.description.peer-reviewpeer-reviewen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.